Currently xBrane is engaged IN THE DEVELOPMENT OF THE FOLLOWING COMPLEX GENERICS
Decapeptyl, Trelstar, Pamorelin, RisperdalConsta, Bydureon, LupronDepot, Sandostatin, Lucentis, Cimzia and Oncaspar are registered trademarks of their respective owners.
TEAM UP WITH US?
Don’t hesitate to contact us. Please fill in the contact form and an Xbrane Executive will contact you.
Or contact directly:
For our Controlled Release Generics
+46 76-309 37 77
For our Biosimilars
+46 73-434 36 19